Plasma Plasminogen Activator Inhibitor-1 as a Biomarker for Disease Activity and Pharmaco-Response Prediction in Pediatric Epilepsy: A Prospective Cohort Study.

Tukey’s multiple comparison test showed highly significant differences between the control and remission groups ( p < 0.0001), the control and active phase groups ( p < 0.0001), as well as between the remission and active phase groups ( p < 0.0001).

also in 68,407 other papers

First, as noted, a numerical trend toward higher values was even shown in the treated subgroup.

also in 691 other papers